← Back to Analyst Consensus 
ALZN Buy
Alzamend Neuro, Inc.
Current Price —
Implied Upside —
Analysts 7
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 19, 2026 | Ascendiant Capital | maintain | Buy → Buy | — | 38% |
| Dec 22, 2025 | Ascendiant Capital | maintain | Buy → Buy | $28 | 38% |
| Sep 25, 2025 | Ascendiant Capital | maintain | Buy → Buy | $42 | 38% |
| Aug 21, 2025 | Ascendiant Capital | maintain | Buy → Buy | $45 | 38% |
| Mar 17, 2025 | Ascendiant Capital | maintain | Buy → Buy | $20 | 38% |
| Dec 16, 2024 | Ascendiant Capital | maintain | Buy → Buy | $32 | 38% |
| Nov 11, 2024 | Ascendiant Capital | maintain | Buy → Buy | $35 | 38% |
Price Target Trend
Apr 16, 2026 Latest: $26 Oct 24, 2026
EPS Estimates
0y $-1.05
Lo: $-1.05 Hi: $-1.05
1 analysts ▲1
0q $-0.23
Lo: $-0.23 Hi: $-0.23
1 analysts ▲1
+1y $-0.87
Lo: $-0.87 Hi: $-0.87
1 analysts +1q $-0.22
Lo: $-0.22 Hi: $-0.22
1 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days